Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

BIO Statement on FDA and NIH Workforce Authorities Modernization Act

Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement regarding the introduction today by Senators Alexander and Murray of the FDA and NIH Workforce Authorities Modernization Act:

J. Craig Venter, Ph.D to Receive the 2016 BIO George Washington Carver Award

The Biotechnology Innovation Organization (BIO) has officially named Dr. J. Craig Venter as the recipient of its 2016 George Washington Carver Award for innovation in industrial biotechnology. 

BIO Applauds Iowa Senate Passage of Renewable Chemical Tax Credit

The Biotechnology Innovation Organization (BIO) today applauded Iowa’s Senate for approving a new five-year production tax credit for renewable chemicals and helping to drive innovation in this new sector. Renewable chemicals will be defined in Iowa’s tax code as having at least 50 percent biobased content and not being used as food, feed or fuel. The value of the tax credit is limited to $105 million over five years.

BIO Statement on Failure to Stop Patchwork of State GMO Labeling Laws

The U.S. Senate was unable to advance a national solution to GMO food labeling.  It is essential for Senate leaders to continue working to reach a much-needed compromise over the coming days, as failure to move forward allows costly and confusing state-based measures such as Vermont’s GMO food labeling law to take effect in July.

BIO’s comments to the USDA on the biomass crop assistance program enacted by the 2008 Farm Bill

Comments are regarding conservation and stewardship requirements, matching payments, establishment costs and annual payments, disclosure of competitively sensitive information, invasiveness determination and review, consistency with existing FSA programs, corporations and publicly traded company participation, eligible materials, and algae.

BIO letter in support of H.R. 5418

To establish a pilot program for educating district court judges on patent related issues.

Small Business Early Stage Investment Program: Legislative Text

The Small Business Early Stage Investment Program would provide matching funds for investment companies who invest in small, high tech companies, including biotech firm.

Cures Acceleration Network: Legislative Text


Mark Rohrbaugh, Director, Office of Technology Transfer, National Institutes of Health (NIH)

Mark Rohrbaugh, Director, Office of Technology Transfer, National Institutes of Health (NIH), US Department of Health & Human Services, USA

The Patent Reform Act of 2007 - Coalition Letter

More than 430 organizations representing American innovation in a wide range of industries in all 50 states wrote Senate leaders to express continued concern with S. 1145.